Skip to content
Menu

BillionToOne, Inc. BLLN

Full chart Compare
Set alert

Price alert · BLLN

All alert types
89.92 USD -0.28 (-0.31%)

Regular-session close

89.92 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

88.00 Day range 91.43
64.03 52-week range 149.97
YTD
+9.87%
1 year
-6.02%

5D -13.11 (-12.72%)

9095100MonTueWedThuFri89.92
Market cap
4.30B
Revenue (ttm)
436.87M
Profit margin
10.52%
EPS (ttm)
0.92
Shares out
43.27M
P/E ratio
97.74
Forward P/E
57.27
YTD return
+9.87%
1-year return
-6.02%
Volume
819.50K
Avg volume
635.75K
Open
88.80
Previous close
90.20
Day's range
88.00 – 91.43
52-week range
64.03 – 149.97
Analysts
Strong Buy
Price target
128.29 (+42.7%)
Earnings date
Mar 3, 2027

Key statistics

50-day average
106.58
200-day average
97.87
Enterprise value
3.89B
Price / sales
9.83
Price / book
7.56
Revenue growth
47.20%
Free cash flow
11.88M
Total cash
561.51M
Total debt
140.45M
Return on equity
13.23%
Short % of float
11.15%

Fundamental scorecard

11 of 25 checks passed on BLLN’s reported financials

ValueGrowthProfitabilityHealthDividend

11of 25 checks passed

  • Value 0 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
BLLN Revenue — quarterly 122.98M
BLLN Net income — quarterly 17.39M
BLLN EPS — quarterly 0.37

Earnings

BLLN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 3, 2027Dec 30, 20260.16———
Nov 4, 2026Sep 30, 20260.1460.32+0.17+119.18%
Aug 5, 2026Jun 30, 20260.18330.15-0.03-18.17%
May 6, 2026Mar 31, 20260.010.34+0.33+3,300.00%
Mar 4, 2026Dec 31, 20250.070.11+0.04+57.14%
Dec 9, 2025Sep 30, 20250.13950.10-0.04-28.32%

Upgrades / downgrades

BLLN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 10, 2026Piper SandlermainOverweightOverweight
Nov 5, 2026JP MorganmainOverweightOverweight
Nov 5, 2026BTIGreitBuyBuy
Oct 1, 2026GuggenheimmainBuyBuy
Sep 2, 2026Canaccord Genuityinit—Buy
Aug 6, 2026JP MorganmainOverweightOverweight

About BillionToOne, Inc.

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States

News

Your note

Sign in to keep a note on BLLN — it syncs with the Stock Master app.

Insider holders

BLLN insider holders
InsiderRelationLatest transactionDateShares held
ATAY OGUZHAN PH.D.Chief Executive OfficerSaleNov 1, 20260
BREMNER THOMAS S.DirectorStock Award(Grant)Jun 9, 202611,350
HUMMING BIRD VENTURES MANAGEMENT NVBeneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityNov 6, 20250
ILERI FIRATDirector and Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Jun 9, 202640,331
KOLLURI KRISHNA KITTUDirector and Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Jun 9, 202611,350
LYNCH THOMAS PGeneral CounselConversion of Exercise of derivative securityOct 12, 202610,700

Institution ownership

BLLN institution ownership
Holder% heldSharesValueReported
Adams Street Partners, LLC3.96%1,711,430153.89MSep 29, 2026
Invesco Ltd.3.20%1,383,470124.40MSep 29, 2026
BAILLIE GIFFORD & CO2.50%1,081,49797.25MSep 29, 2026
Price (T.Rowe) Associates Inc2.42%1,046,60994.11MSep 29, 2026
Vanguard Capital Management LLC2.35%1,018,30191.57MSep 29, 2026
Vanguard Portfolio Management LLC1.90%822,29573.94MSep 29, 2026

Fund ownership

BLLN fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.67%724,08865.11MJun 29, 2026
AIM Counselor Series TRT -Invesco Discovery Fd.1.23%531,37047.78MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.21%522,86447.02MJun 29, 2026
T. Rowe Price Health Sciences Fund, Inc.0.87%377,57533.95MJun 29, 2026
BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd.0.66%286,83025.79MJun 29, 2026
Capitol Series Trust-FullerThaler Behavioral Small-Cap Growth Fund0.64%275,00024.73MJun 29, 2026